ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
5.45 / 10Overall Score
NeturalInvestment Rating
5.45 / 10Overall Score
NeturalInvestment Rating
Is ARWR a Good Buy Right Now?
- Based on a composite score of 5.45/10, we rate ARWR as a Netural. Our analysis breaks down into 5.64/10 for Fundamentals, 4.36/10 for Technicals, and 5.89/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of ARWR?
Is ARWR undervalued or overvalued?
What is the analyst consensus for ARWR?
Is ARWR a Good Buy Right Now?
- Based on a composite score of 5.45/10, we rate ARWR as a Netural. Our analysis breaks down into 5.64/10 for Fundamentals, 4.36/10 for Technicals, and 5.89/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ARWR undervalued or overvalued?
Technical Analysis of ARWR?
What is the analyst consensus for ARWR?
